RPO 4000 IU INJECTION

RPO 4000IU injection combines active ingredients like Recombinant Human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medication is used to treat anemia that is caused by chronic kidney illness (CKD), as well as chemotherapy for cancer or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of losing blood because of planned surgery and other surgical procedures.
RPO 4000IU injections should not be administered to those who are hypersensitive to its component or components, hypertension that is uncontrolled active thrombotic microangiopathy (TMA) and purified red cell aplasia (PRCA) and seizures that are uncontrolled and pregnancy or lactation. It is also recommended to use it carefully in patients with a history of blood clots or heart disease, kidney disease, stroke, Thalassemia in the liver, sickle-cell anemia, myelodysplastic disorder, cancer, or leukemia. It is recommended to use only for children younger than 18 years old in cases where the benefits are more significant than the risks. Older patients must be monitored closely for any adverse effects. Before you begin this medication, it’s essential to consult your doctor regarding the advantages and risks of RPO 4000IU injection.